opioids
European Commission approves first and only long-acting opioid dependence therapy
November 26, 2018Sales and Marketing Europe, opioid crisis, opioids, pharma
Europe has seen its first and only approval of a long-acting therapy for opioid dependence, as the European Commission (EC) …
Opioid use disorder market to hit $4.8 billion by 2027, says GlobalData
November 26, 2018Sales and Marketing US, opioid crisis, opioids, pharma
New findings released by analytics firm GlobalData indicates that the market for opioid use disorder therapies is set to grow …
Opioid dependency therapy price hiked 600% since 2014, Senate investigators find
November 20, 2018Manufacturing and Production, Sales and Marketing Evzio, Kaleo, Senate, US, naloxone, opioid crisis, opioid epidemic, opioids, pharma
Senate investigators have found that Virginia-based drugmaker Kaleo hiked the price of its opioid dependency therapy Evzio (naloxone) by as …
FDA commissioner Scott Gottlieb says that more rigorous approval process would be unique to opioids
November 12, 2018Sales and Marketing FDA, Gottlieb, opioid crisis, opioids
Food and Drug Administration (FDA) commissioner Scott Gottlieb has said that if a more rigorous approval process is introduced for …
Alabama’s biggest insurer will no longer cover OxyContin prescriptions
November 9, 2018Medical Communications Alabama, Blue Cross and Blue Shield, OxyContin, insurance, opioids
The state of Alabama’s biggest insurer Blue Cross and Blue Shield will no long cover opioid painkiller OxyContin. The decision …
The November 2018 issue of Pharmafocus is available to read online now!
November 6, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EU, President trump, Trump, anti vaxxer, brexit, clinical trials, opioid crisis, opioids, pharma, vaccines
As the US continues to battle the demons in its healthcare system, Donald Trump looks like he may finally make …
FDA controversially approves potent opioid up to ten times stronger than fentanyl
November 6, 2018Sales and Marketing Dsuvia, FDA, US, fentanyl, opioid crisis, opioids, pharma
Despite voices of criticism, the FDA has opted to approve AcelRX’s Dsuvia (sufentanil), an opioid medication said to be five …
FDA advisory panel approves AcelRx’s opioid pain drug Dsuvia
October 15, 2018Sales and Marketing FDA, approval, comittee, opioids
An FDA advisory panel voted 10 to 3 to recommend the approval of AcelRx Pharmaceuticals’ opioid pain drug Dsuvia (sufentanil) …
FDA expand REMS education program in effort against opioid crisis
September 19, 2018Research and Development FDA, IR, opioid crisis, opioids, rems
The US Food and Drug Administration is set to introduce a requirement that all healthcare providers be offered educational training …
Emergent snaps up Adapt and its opioid overdose therapy for $735m
August 29, 2018Research and Development, Sales and Marketing Emergent, Narcan, naloxone, opioid crisis, opioids, pharma
Emergent BioSolutions has announced it has signed an agreement to acquire Adapt Pharma at a valuation of $735 million, a …
Pain Therapeutics refocuses on Alzheimer’s after FDA turns down abuse-deterrent opioid painkiller
August 7, 2018Manufacturing and Production, Research and Development, Sales and Marketing FDA, Remoxy, opioid crisis, opioids, pain therapeutics, pharma
The FDA has voted to reject Texas-based Pain Therapeutics’ abuse deterrent opioid painkiller Remoxy (oxycodone), leading the company to consider …
Fentanyl-related deaths spike in England and Wales
August 7, 2018Manufacturing and Production fentanyl, heroin, ons, opioid crisis, opioids, statistics
Deaths linked to the powerful opioid fentanyl have increased by 30% in England and Wales. Figures from the Office for …
Allergan sues Pfizer over opioid crisis lawsuits
August 3, 2018Medical Communications Allergan, Litigation, Pfizer, lawsuits, opioid crisis, opioids
Allergan are suing American pharma giant Pfizer over potential damages that they may be forced to pay relating to hundreds …
FDA panels vote to reject Pain Therapeutics’ abuse-deterrent opioid drug
June 27, 2018Research and Development, Sales and Marketing Remoxy, opioid crisis, opioids, pain therapeutics, pharma
Drug development firm Pain Therapeutics has revealed that its abuse-deterrent opioid medication Remoxy has been rejected by an FDA advisory …
Purdue culls 350 positions, eradicates sales force
June 21, 2018Medical Communications, Sales and Marketing Purdue Pharma, opioid crisis, opioids, pharma
Bowing to the pressure applied by external groups for the part it has played in the ongoing opioid crisis, Purdue …
